[ORGANIZATION]
CASGEVY
Featured in 1 tracked story · first seen
Situations
FDA review of Grail Galleri cancer blood test
2 clusters · 2 sources · last updated
Latest: Biotech firms Grail and CRISPR Therapeutics see regulatory developments
The U.S. Food and Drug Administration (FDA) has scheduled an advisory committee meeting for September 23, 2026, to review the premarket approval application for Grail Inc.’s Galleri multi-cancer early detection (MCED) bl